Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD of CVS HEALTH Corp from 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary
CVS HEALTH Corp quarterly/annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and change rate from 2016 to Q3 2025.
  • CVS HEALTH Corp Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending 30 Sep 2025 was -$3.48B, a 3416% decline year-over-year.
  • CVS HEALTH Corp Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending 30 Sep 2025 was $2.91B, a 56.8% decline year-over-year.
  • CVS HEALTH Corp annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2024 was $6.15B, a 45% decline from 2023.
  • CVS HEALTH Corp annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was $11.2B, a 91.5% increase from 2022.
  • CVS HEALTH Corp annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was $5.84B, a 44.6% decline from 2021.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Change (%)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Annual Change (%)

CVS HEALTH Corp Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $2.91B -$3.48B -$3.59B -3416% 01 Jul 2025 30 Sep 2025 10-Q 29 Oct 2025
Q2 2025 $6.5B $1.65B -$690M -29.5% 01 Apr 2025 30 Jun 2025 10-Q 31 Jul 2025
Q1 2025 $7.19B $2.62B +$1.04B +65.6% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025
Q4 2024 $6.15B $2.13B -$579M -21.4% 01 Oct 2024 31 Dec 2024 10-K 12 Feb 2025
Q3 2024 $6.73B $105M -$2.91B -96.5% 01 Jul 2024 30 Sep 2024 10-Q 29 Oct 2025
Q2 2024 $9.64B $2.34B -$233M -9.07% 01 Apr 2024 30 Jun 2024 10-Q 31 Jul 2025
Q1 2024 $9.87B $1.58B -$1.3B -45.1% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025
Q4 2023 $11.2B $2.71B -$445M -14.1% 01 Oct 2023 31 Dec 2023 10-K 12 Feb 2025
Q3 2023 $11.6B $3.02B +$7.46B 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024
Q2 2023 $4.16B $2.57B -$1.56B -37.8% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024
Q1 2023 $5.71B $2.88B -$122M -4.07% 01 Jan 2023 31 Mar 2023 10-Q 01 May 2024
Q4 2022 $5.84B $3.15B +$1.46B +86.7% 01 Oct 2022 31 Dec 2022 10-K 12 Feb 2025
Q3 2022 $4.37B -$4.44B -$6.59B -307% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023
Q2 2022 $11B $4.13B +$394M +10.5% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023
Q1 2022 $10.6B $3B +$31M +1.04% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023
Q4 2021 $10.5B $1.69B 01 Oct 2021 31 Dec 2021 10-K 07 Feb 2024
Q3 2021 $2.15B +$339M +18.8% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 $3.74B 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022
Q1 2021 $2.97B 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022
Q3 2020 $1.81B 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021

CVS HEALTH Corp Annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $6.15B -$5.03B -45% 01 Jan 2024 31 Dec 2024 10-K 12 Feb 2025
2023 $11.2B +$5.34B +91.5% 01 Jan 2023 31 Dec 2023 10-K 12 Feb 2025
2022 $5.84B -$4.7B -44.6% 01 Jan 2022 31 Dec 2022 10-K 12 Feb 2025
2021 $10.5B +$767M +7.85% 01 Jan 2021 31 Dec 2021 10-K 07 Feb 2024
2020 $9.77B +$773M +8.59% 01 Jan 2020 31 Dec 2020 8-K 25 May 2023
2019 $9B +$7.59B +540% 01 Jan 2019 31 Dec 2019 10-K 09 Feb 2022
2018 $1.41B -$6.86B -83% 01 Jan 2018 31 Dec 2018 8-K 08 Aug 2019
2017 $8.27B -$369M -4.27% 01 Jan 2017 31 Dec 2017 8-K 08 Aug 2019
2016 $8.64B 01 Jan 2016 31 Dec 2016 8-K 08 Aug 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.